Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSP #565 - Combination Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D Study)

NCT00555217 is registered in ClinicalTrials.gov with US Department of Veterans Affairs as lead sponsor.

NCT NCT00555217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00555217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSP #565 - Combination Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D Study)
Lead sponsor
US Department of Veterans Affairs
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2008
Completion date
October 31, 2014
Enrollment
1,448 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, nephropathy, type 2 diabetes